Delivery Order HHSN261201300005I-HHSN26100011
Award Date
9/19/16
Potential Completion Date
12/18/17
Potential Value
$278K
Federal Agency
National Cancer Institute
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fremont, CA 94538, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the National Cancer Institute, a civilian agency, to the Cancer Prevention Institute of California. The $137,904 contract is for evaluating the feasibility of and potential biases in supplementing cancer registry data using external sources for the Surveillance, Epidemiology, and End Results (SEER) program. The period of performance is from September 18, 2015 to September 17, 2016. This contract award does not have a set-aside designation.
This is a federal contract award from the National Cancer Institute (NCI), a civilian agency, to the Cancer Prevention Institute of California. The contract is for core infrastructure support for the Surveillance, Epidemiology and End Results (SEER) program, with a period of performance from May 1, 2015 to April 30, 2018 and a ceiling value of $12,672,427.89. The contract is a Delivery Order with a Cost Plus Fixed Fee pricing type and does not have a set-aside designation. The Cancer...
<p>This is a firm fixed-price delivery order contract awarded by the National Cancer Institute, a civilian agency, to the Cancer Prevention Institute of California. The contract, valued at $176,337.00, is for a Patterns of Care/Quality of Care Study (POC) related to the Surveillance, Epidemiology and End Results (SEER) Program. The period of performance is from August 15, 2016 through August 14, 2017. This contract does not have a set-aside designation.</p>
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to the Cancer Prevention Institute of California. The contract, valued at $130,809.00, is for the Patterns of Care/Quality of Care Study for diagnosis year 2014 under the Surveillance, Epidemiology and End Results (SEER) program. The contract does not have a set-aside designation. The contract delivers products and services related to the SEER program, which is a major NCI program focused on...
This is a federal contract awarded by the National Cancer Institute (NCI), a civilian agency, to the Cancer Prevention Institute of California. The contract, with a ceiling value of $101,968.00, is for research and development related to the quality control of electronic pathology (e-path) results. The contract is a delivery order under the Surveillance, Epidemiology and End Results (SEER) Program, a major NCI initiative. The contract does not have a set-aside designation and was awarded on...
This is a definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to the Cancer Prevention Institute of California. The contract is for the Surveillance, Epidemiology, and End Results (SEER) Program, which involves deobligation of funds. The contract has a ceiling value of $415,386,045.00 and a completion date of July 31, 2010. It is a cost-sharing contract and was not set aside for any specific type of business. This contract appears to be part of the NCI's...
This is a federal contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the Public Health Institute (PHI), a non-profit organization. The contract, valued at $17,514,848.38, is for the Surveillance, Epidemiology and End Results (SEER) program, which collects and publishes cancer incidence and survival data from population-based cancer registries. The contract is a definitive, cost-sharing contract with a period of performance ending...
This is a definitive contract awarded by the National Cancer Institute, a civilian agency under the Department of Health and Human Services, to the Cancer Prevention Institute of California. The contract, valued at $36,533,061.14, is for the Surveillance, Epidemiology, and End Results (SEER) program, which conducts cancer surveillance and epidemiological research. The contract has no set-aside designation and has a period of performance ending on July 31, 2017. The Cancer Prevention Institute of...
This is a $17,528,318.00 delivery order contract awarded by the National Cancer Institute to the Department of Public Health Illinois, a state government entity, to provide core infrastructure support for the Surveillance Epidemiology and End Results (SEER) Program. The contract is part of a larger $500 million multiple-award Indefinite Delivery Vehicle (IDV) that supports the SEER Program, which collects and publishes cancer incidence and survival data from population-based cancer registries....
This is a federal contract award with ID 75N91018D00009|75N91018F00001, issued by the National Cancer Institute (NCI) to the Public Health Institute (PHI), a non-profit organization. The contract is for the Surveillance Epidemiology and End Results (SEER) Core Infrastructure program, with a ceiling value of $45,063,997.94 and a period of performance ending on April 30, 2028. The contract was awarded on May 1, 2018 and does not have a set-aside designation. PHI has a strong track record of...